Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 2008;112:71-78
© 2008 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Rodriguez, A. O.
Right arrow Articles by Smith, L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodriguez, A. O.
Right arrow Articles by Smith, L.
Related Collections
Right arrow General obstetrics
Right arrow General surgery
Right arrow Gynecologic oncology
Right arrow Breast Disease
Right arrow Medical complications of pregnancy

ORIGINAL RESEARCH

Evidence of Poorer Survival in Pregnancy-Associated Breast Cancer

Anne O. Rodriguez, MD1, Helen Chew, MD1, Rosemary Cress, DrPH2, Guibo Xing, PhD1, Sherrie McElvy, MD3, Beate Danielsen, PhD4 and Lloyd Smith, MD, PhD1

From the 1University of California Davis Medical Center, Sacramento, California; 2California Cancer Registry, Sacramento, California; 3Sutter Medical Center, Sacramento, CA; and 4Health Information Solutions, Sacramento, California.

OBJECTIVE: To compare stage distribution, tumor characteristics, and survival outcome in pregnancy-associated and non–pregnancy-associated breast cancer, and to evaluate pregnancy as a risk factor for mortality in breast cancer.

METHODS: The California Cancer Registry (1991–1999) was linked with the California Patient Discharge Data Set to identify women with breast cancer occurring within 9 months before or 1 year after an obstetric delivery. Age-matched, non–pregnancy-associated breast cancer controls were also identified. Demographics, cancer stage, tumor size, histology, hormone receptor status, type of treatment, and survival were reviewed and compared. Predictive factors for death from breast cancer were identified using proportional hazards modeling.

RESULTS: Seven hundred ninety-seven pregnancy-associated breast cancer cases were compared with 4,177 non–pregnancy-associated breast cancer controls. Pregnancy-associated breast cancer cases were significantly more likely to have more advanced stage, larger primary tumor, hormone receptor negative tumor, and mastectomy as a component of their treatment. In survival analysis, pregnancy-associated breast cancer had a higher death rate than non–pregnancy-associated breast cancer (39.2% compared with 33.4%, P=.002). In a multivariable analysis, advancing stage (2.22–10.76 times the risk of death for stages II–IV), race (African Americans had 68% increased risk of death over non-Hispanic whites), hormone receptor–negative tumors (20% increased risk of death over receptor-positive tumors), and pregnancy (14% increased risk of death over nonpregnant women) all were significant predictors of death.

CONCLUSION: Pregnancy-associated breast cancer presented with more advanced disease, larger tumors, and increased percentage of hormone receptor–negative tumors. When controlled for stage, race, and hormone receptor status, pregnancy-associated breast cancer cases had a slightly higher risk of death, even when only localized-stage disease was considered.

LEVEL OF EVIDENCE: II




This article has been cited by other articles:


Home page
JWatch Women's HealthHome page
Pregnancy Worsens Breast Cancer Outcomes
Journal Watch Women's Health, August 14, 2008; 2008(814): 5 - 5.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American College of Obstetricians and Gynecologists.